The North America Carrier Screening Market would witness market growth of 11.04% CAGR during the forecast period (2021-2027).
Carrier screening is the diagnosis of atypical chromosomal or genetic disorders from a carrier individual who inherits one abnormal gene from one of their parents. Carrier frequently displays zero symptoms of the genetic diseases that they forward an abnormal gene. Factors such as increasing cases of genetic diseases, growing availability & affordability of tests, and increasing launches of innovative products are likely to boost the growth and demand for the carrier screening market during the forecast period.
North America is the leading region of the carrier screening market and would display the same trend even during the forecasting years. This is because Genetic disease is the major cause of infant deaths in the United States, responsible for around one-fifth of the total yearly infant mortality, according to the data published by the World Health Organization. The constant technological developments in genomic medicine and technological platforms have made feasible cost-effective, and pan-ethnic, expanded carrier screening that allows obstetric care vendors to provide screening for above 100 recessive genetic diseases.
The technology segment would emerge as the leading segment during the forecasting period. This is credited to the constant developments in genetic analysis tools, like assays built on next-generation sequencing and microarray technologies, molecular diagnostics, and advancing the kind for heritable disorders.
The USA market dominated the North America Carrier Screening Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $737.7 million by 2027. The Canada market is experiencing a CAGR of 11.2% during (2021 - 2027). Additionally, The Mexico market is estimated to witness a CAGR of 13.3% during (2021 - 2027).
Based on Technology, the market is segmented into DNA Sequencing, Microarrays, Polymerase Chain Reaction and Other technology. Based on End user, the market is segmented into Hospital and Clinics, Physician Offices, Reference Laboratories and Other End Users. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Carrier Screening Market is Estimated to reach $2,501.94 Million by 2027, at a CAGR of 10.81%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Quest Diagnostics, Incorporated, Thermo Fisher Scientific, Illumina, Inc., Eurofins Scientific Group, Invitae Corporation, OPKO Health, Inc., Fulgent Genetics, Sema4 OpCo, Inc., Myriad Genetics, Inc., and Natera, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Expanded Carrier Screening and
- Targeted Disease Carrier Screening
By Technology
- DNA Sequencing
- Microarrays
- Polymerase Chain Reaction and
- Other technology
By End User
- Hospital and Clinics
- Physician Offices
- Reference Laboratories and
- Other End Users
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Quest Diagnostics, Incorporated
- Thermo Fisher Scientific
- Illumina, Inc.
- Eurofins Scientific Group
- Invitae Corporation
- OPKO Health, Inc.
- Fulgent Genetics
- Sema4 OpCo, Inc.
- Myriad Genetics, Inc.
- Natera, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Carrier Screening Market, by Type
1.4.2 North America Carrier Screening Market, by Technology
1.4.3 North America Carrier Screening Market, by End User
1.4.4 North America Carrier Screening Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2017, Jun – 2021, Jun) Leading Players
Chapter 4. North America Carrier Screening Market by Type
4.1 North America Expanded Carrier Screening Market by Country
4.2 North America Targeted Disease Carrier Screening Market by Country
Chapter 5. North America Carrier Screening Market by Technology
5.1 North America DNA Sequencing Market by Country
5.2 North America Microarrays Market by Country
5.3 North America Polymerase Chain Reaction Market by Country
5.4 North America Other Technologies Market by Country
Chapter 6. North America Carrier Screening Market by End user
6.1 North America Hospital and Clinics Market by Country
6.2 North America Physician Offices Market by Country
6.3 North America Reference Laboratories Market by Country
6.4 North America Other End user Market by Country
Chapter 7. North America Carrier Screening Market by Country
7.1 USA Carrier Screening Market
7.1.1 USA Carrier Screening Market by Type
7.1.2 USA Carrier Screening Market by Technology
7.1.3 USA Carrier Screening Market by End user
7.2 Canada Carrier Screening Market
7.2.1 Canada Carrier Screening Market by Type
7.2.2 Canada Carrier Screening Market by Technology
7.2.3 Canada Carrier Screening Market by End user
7.3 Mexico Carrier Screening Market
7.3.1 Mexico Carrier Screening Market by Type
7.3.2 Mexico Carrier Screening Market by Technology
7.3.3 Mexico Carrier Screening Market by End user
7.4 Rest of North America Carrier Screening Market
7.4.1 Rest of North America Carrier Screening Market by Type
7.4.2 Rest of North America Carrier Screening Market by Technology
7.4.3 Rest of North America Carrier Screening Market by End user
Chapter 8. Company Profiles
8.1 Quest Diagnostics, Incorporated
8.1.1 Company Overview
8.1.1 Financial Analysis
8.1.2 Recent strategies and developments:
8.1.2.1 Partnerships, Collaborations, and Agreements:
8.1.2.2 Product Launches and Product Expansions:
8.1.2.3 Acquisition and Mergers:
8.2 Thermo Fisher Scientific, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 Illumina, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.4 Eurofins Scientific Group
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Recent strategies and developments:
8.4.4.1 Partnerships, Collaborations, and Agreements:
8.4.4.2 Acquisition and Mergers:
8.5 Invitae Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.5.5.2 Acquisition and Mergers:
8.6 OPKO Health, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Acquisition and Mergers:
8.7 Fulgent Genetics
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.8 Sema4 OpCo, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Product Launches and Product Expansions:
8.9 Myriad Genetics, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.5.2 Product Launches and Product Expansions:
8.1 Natera Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.5.2 Product Launches and Product Expansions:
TABLE 1 North America Carrier Screening Market, 2017 - 2020, USD Million
TABLE 2 North America Carrier Screening Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Carrier Screening Market
TABLE 4 Product Launches And Product Expansions– Carrier Screening Market
TABLE 5 Acquisition and Mergers– Carrier Screening Market
TABLE 6 North America Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 7 North America Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 8 North America Expanded Carrier Screening Market by Country, 2017 - 2020, USD Million
TABLE 9 North America Expanded Carrier Screening Market by Country, 2021 - 2027, USD Million
TABLE 10 North America Targeted Disease Carrier Screening Market by Country, 2017 - 2020, USD Million
TABLE 11 North America Targeted Disease Carrier Screening Market by Country, 2021 - 2027, USD Million
TABLE 12 North America Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 13 North America Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 14 North America DNA Sequencing Market by Country, 2017 - 2020, USD Million
TABLE 15 North America DNA Sequencing Market by Country, 2021 - 2027, USD Million
TABLE 16 North America Microarrays Market by Country, 2017 - 2020, USD Million
TABLE 17 North America Microarrays Market by Country, 2021 - 2027, USD Million
TABLE 18 North America Polymerase Chain Reaction Market by Country, 2017 - 2020, USD Million
TABLE 19 North America Polymerase Chain Reaction Market by Country, 2021 - 2027, USD Million
TABLE 20 North America Other Technologies Market by Country, 2017 - 2020, USD Million
TABLE 21 North America Other Technologies Market by Country, 2021 - 2027, USD Million
TABLE 22 North America Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 23 North America Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 24 North America Hospital and Clinics Market by Country, 2017 - 2020, USD Million
TABLE 25 North America Hospital and Clinics Market by Country, 2021 - 2027, USD Million
TABLE 26 North America Physician Offices Market by Country, 2017 - 2020, USD Million
TABLE 27 North America Physician Offices Market by Country, 2021 - 2027, USD Million
TABLE 28 North America Reference Laboratories Market by Country, 2017 - 2020, USD Million
TABLE 29 North America Reference Laboratories Market by Country, 2021 - 2027, USD Million
TABLE 30 North America Other End user Market by Country, 2017 - 2020, USD Million
TABLE 31 North America Other End user Market by Country, 2021 - 2027, USD Million
TABLE 32 North America Carrier Screening Market by Country, 2017 - 2020, USD Million
TABLE 33 North America Carrier Screening Market by Country, 2021 - 2027, USD Million
TABLE 34 USA Carrier Screening Market, 2017 - 2020, USD Million
TABLE 35 USA Carrier Screening Market, 2021 - 2027, USD Million
TABLE 36 USA Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 37 USA Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 38 USA Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 39 USA Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 40 USA Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 41 USA Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 42 Canada Carrier Screening Market, 2017 - 2020, USD Million
TABLE 43 Canada Carrier Screening Market, 2021 - 2027, USD Million
TABLE 44 Canada Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 45 Canada Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 46 Canada Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 47 Canada Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 48 Canada Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 49 Canada Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 50 Mexico Carrier Screening Market, 2017 - 2020, USD Million
TABLE 51 Mexico Carrier Screening Market, 2021 - 2027, USD Million
TABLE 52 Mexico Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 53 Mexico Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 54 Mexico Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 55 Mexico Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 56 Mexico Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 57 Mexico Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 58 Rest of North America Carrier Screening Market, 2017 - 2020, USD Million
TABLE 59 Rest of North America Carrier Screening Market, 2021 - 2027, USD Million
TABLE 60 Rest of North America Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 61 Rest of North America Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 62 Rest of North America Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 63 Rest of North America Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 64 Rest of North America Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 65 Rest of North America Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 66 Key Information – Quest Diagnostics, Incorporated
TABLE 67 Key Information – Thermo Fisher Scientific, Inc.
TABLE 68 key information – Illumina, Inc.
TABLE 69 Key Information – Eurofins Scientific Group
TABLE 70 Key Information – Invitae Corporation
TABLE 71 Key Information – OPKO Health, Inc.
TABLE 72 Key Information – Fulgent Genetics
TABLE 73 Key Information – Sema4 OpCo, Inc.
TABLE 74 Key Information – Myriad Genetics, Inc.
TABLE 75 Key Information – Natera Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Product Launches and Product Expansions : 2017, Jun – 2021, Jun) Leading Players
FIG 5 Recent strategies and developments: Quest Diagnostics
FIG 6 Swot analysis: thermo fisher scientific, inc.
FIG 7 Recent strategies and developments: Sema4 OpCo, Inc.